8. Income Taxes

(Benefit) provision of Income taxes consists of the following:

	For The Years Ended March 31,
	2016		2015
Current:
Federal	$	(9,979)	$	147,945
State		66,678		67,769
		56,699		215,714

Deferred:
Federal		(81,277)		(36,390)
State		(46,459)		(15,532)
		(127,736)		(51,922)

(Benefit) provision for income taxes	$	(71,037)	$	163,792

The Company uses the liability method of accounting for income taxes as set forth in ASC 740. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates. As of March 31, 2016, the Company had federal and California tax net operating loss carryforwards of approximately $12.2 million and $12.3 million, respectively. The federal and California net operating loss carryforwards will expire at various dates from 2026 through 2036. Pursuant to Internal Revenue Code Sections 382 and 383, use of the Company’s net operating loss and credit carryforwards may be limited if a cumulative change in ownership of more than 50% occurs within any three-year period since the last ownership change. The Company may have had a change in control under these Sections. However, the Company does not anticipate performing a complete analysis of the limitation on the annual use of the net operating loss and tax credit carryforwards until the time that it projects it will be able to utilize these tax attributes.

Significant components of the Company’s deferred tax assets (liabilities) as of March 31, 2016 and March 31, 2015 are shown below. A valuation allowance of $8,369,878 and $4,447,029 as of March 31, 2016 and March 31, 2015, respectively, has been established against the Company’s deferred tax assets as realization of such assets is uncertain. The Company’s effective tax rate is different from the federal statutory rate of 34% due primarily to operating losses that receive no tax benefit as a result of a valuation allowance recorded for such losses.

Deferred tax assets (liabilities) consist of the following:

	For The Years Ended March 31,
	2016		2015
Deferred tax assets (liabilities):
State taxes	$	15,114	$	17,062
Stock options		2,617,037		2,177,276
Accrued payroll and related costs		16,222		1,529
Accrued hospital pool deficit		329,430		-
Net operating loss carryforward		4,754,165		2,208,522
Property and equipment		1,588		(3,170)
Acquired intangible assets		65,748		(194,883)
Other		527,095		69,478

Net deferred tax assets (liabilities) before valuation allowance		8,326,399		4,275,814
Valuation allowance		(8,369,878)		(4,447,029)

Net deferred tax liabilities	$	(43,479)	$	(171,215)

The provision for income taxes differs from the amount computed by applying the federal income tax rate as follows:

	For The Years Ended March 31,
	2016			2015
Tax provision at U.S. Federal statutory rates		34.0	%		34.0	%
State income taxes net of federal benefit		(0.3)	%		(3.2)	%
Nondeductible permanent items		(0.7)	%		(5.9)	%
Nontaxable entities		5.4	%		(4.3)	%
Other		1.9	%		0.5	%
Change in valuation allowance		(39.4)	%		(34.9)	%

Effective income tax rate		0.9	%		(13.8)	%

As of March 31, 2016 and March 31, 2015, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.

The Company is subject to U.S. federal income tax as well as income tax of multiple state tax jurisdictions. The Company and its subsidiaries’ state income tax returns are open to audit under the statute of limitations for the years ended January 31, 2012 through 2016. The Company does not anticipate material unrecognized tax benefits within the next 12 months.